INDmoney
Aurinia Pharmaceuticals Inc Stock Performance
as on March 7, 2026 at 3:11 am IST
Day's Low
Day's High
$14.16$14.55
0.56%
Downside
2.18%
Upside
52 Week's Low
52 Week's High
$6.83$16.5452.07%
Downside
16.15%
Upside
Aurinia Pharmaceuticals Inc share price movements today
- Previous Close
- $14.74
- Open
- $14.50
- Volume
- 282.8K
- Day's Low - High
- $14.16 - $14.55
- 52 Week Low - High
- $6.83 - $16.54
Aurinia Pharmaceuticals Inc Historical Returns
- 1 Month Return
- + 2.08 %
- 3 Month Return
- -5.63 %
- 1 Year Return
- + 79.98 %
- 3 Year Return
- + 60.74 %
- 5 Year Return
- + 12.61 %
Aurinia Pharmaceuticals Inc Stock Fundamentals & Key Indicators
Check Aurinia Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.0B
EPS (TTM)
0.835
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
150.73%
PE Ratio (TTM)
26.86
Industry PE ratio
-3.1180442804428044
PEG Ratio
0EBITDA
135.7M
Revenue (TTM)
283.1M
Profit Margin
101.47%
Return On Equity TTM
59.91%
Aurinia Pharmaceuticals Inc Stock Valuation
Track how Aurinia Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Aurinia Pharmaceuticals Inc in the last 5 years
Lowest (-56.37x)
September 30, 2024
Industry (-3.12x)
March 6, 2026
Today (26.86x)
March 6, 2026
Highest (90.66x)
December 31, 2024
Today’s Price to Earnings Ratio: 26.86x
Aurinia Pharmaceuticals Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Aurinia Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $2.0B | 12.61% | 26.86 | 101.47% | |
| BUY | $43.4B | 123.52% | 141.08 | 8.45% | |
| BUY | $121.4B | 117.39% | 31.15 | 32.94% | |
| NA | $33.1B | NA | 586.31 | 5.37% | |
| BUY | $83.3B | 65.72% | 18.98 | 31.41% |
Stock Returns calculator for Aurinia Pharmaceuticals Inc Stock including INR - Dollar returns
The Aurinia Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Aurinia Pharmaceuticals Inc investment value today
Current value as on today
₹1,79,235
Returns
₹79,235
(+79.24%)
Returns from Aurinia Pharmaceuticals Inc Stock
₹73,871 (+73.87%)
Dollar Returns*
₹5,365 (+5.36%)
Analyst Recommendation on Aurinia Pharmaceuticals Inc Stock
Based on 13 analysts
84.62%
Buy
15.38%
Hold
0.00%
Sell
Based on 13 analysts, 84.62% of analysts recommend a 'BUY' rating for Aurinia Pharmaceuticals Inc. Average target price of $17
Aurinia Pharmaceuticals Inc Share Price Target
Get share price movements and forecasts by analysts on Aurinia Pharmaceuticals Inc.
What analysts predicted
16.24%UPSIDE
Target Price
$17
Current Price
$14.24
Analyzed by
13 Analysts
Target
$17.00
Aurinia Pharmaceuticals Inc target price $17, a slight upside of 16.24% compared to current price of $14.24. According to 13 analysts rating.
Aurinia Pharmaceuticals Inc Stock’s Investor Sentiment and Interest
Search interest for Aurinia Pharmaceuticals Inc Stock has decreased by -24% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Aurinia Pharmaceuticals Inc Quarterly Profit & Loss
All numbers in Millions USD
Aurinia Pharmaceuticals Inc Annual Profit & Loss
All numbers in Millions USD
Aurinia Pharmaceuticals Inc Quarterly Cash Flow
All numbers in Millions USD
Aurinia Pharmaceuticals Inc Annual Cash Flow
All numbers in Millions USD
Aurinia Pharmaceuticals Inc News & Key Events
Today's Timeline - 15 October
Wed, 04:13 PM
-Aurinia Pharmaceuticals to present new LUPKYNIS data at ACR and ASN conferences, enhancing understanding of lupus nephritis treatment.
Insights on Aurinia Pharmaceuticals Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, AUPH stock has moved up by 4.0%
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, AUPH has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, 21.51M → 210.79M (in $), with an average increase of 58.4% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 5 quarters, 59.86M → 77.11M (in $), with an average increase of 6.1% per quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, AUPH has outperformed top 5 stocks with highest market-cap in its industry
About Aurinia Pharmaceuticals Inc
| Organisation | Aurinia Pharmaceuticals Inc |
| Headquarters | #140, 14315 ? 118 Avenue, Edmonton, AB, Canada, T5L 4S6 |
| Industry | Health Technology |
| CEO | Mr. Peter S. Greenleaf M.B.A. |
| E-voting on shares | Click here to vote |
Key Management of Aurinia Pharmaceuticals Inc
Name | Title |
|---|---|
Mr. Peter S. Greenleaf M.B.A. | President, CEO & Director |
Dr. Gregory F. Keenan M.D. | Senior VP & Chief Medical Officer |
Mr. Michael Gammons | Vice President & Chief Information Officer |
Mr. Richard Lewis | Vice President of Sales |
Mr. Eric Victory | Vice President of Corporate Development |
Ms. Lucy Shieh | Vice President of Human Resources & Operations |
Dr. Premchandran Ramiya Ph.D. | Senior Vice President of Manufacturing & Supply Chain |
Mr. Matthew Maxwell Donley M.B.A. | Chief Operations Officer |
Mr. Stephen P. Robertson | Executive VP, General Counsel, Corporate Secretary & Chief Compliance Officer |
Ms. Andrea Levin Christopher | Executive Director of Corporate Communications & Investor Relations |
FAQs
What is Aurinia Pharmaceuticals Inc share price today?
Aurinia Pharmaceuticals Inc share price today is $14.24 as on . Aurinia Pharmaceuticals Inc share today touched a day high of $14.55 and a low of $14.16.
What is the 52 week high and 52 week low for Aurinia Pharmaceuticals Inc share?
Aurinia Pharmaceuticals Inc share touched a 52 week high of $16.54 on and a 52 week low of $6.83 on . Aurinia Pharmaceuticals Inc stock price today i.e. is trending at $14.24,which is 13.91% down from its 52 week high and 108.64% up from its 52 week low.
What is Aurinia Pharmaceuticals Inc's market capitalisation today?
Aurinia Pharmaceuticals Inc market capitalisation is $0.00T as on .
How to invest in Aurinia Pharmaceuticals Inc Stock (AUPH) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Aurinia Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aurinia Pharmaceuticals Inc Shares that will get you 0.1053 shares as per Aurinia Pharmaceuticals Inc share price of $14.24 per share as on March 6, 2026 at 9:41 pm IST.
What is the minimum amount required to buy Aurinia Pharmaceuticals Inc Stock (AUPH) from India?
Indian investors can start investing in Aurinia Pharmaceuticals Inc (AUPH) shares with as little as ₹91.708 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹917.08 in Aurinia Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Aurinia Pharmaceuticals Inc share’s latest price of $14.24 as on March 6, 2026 at 9:41 pm IST, you will get 0.7022 shares of Aurinia Pharmaceuticals Inc. Learn more about
fractional shares .
What are the returns that Aurinia Pharmaceuticals Inc has given to Indian investors in the last 5 years?
Aurinia Pharmaceuticals Inc stock has given 12.61% share price returns and 25.48% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?